Lv4
800 积分 2021-05-09 加入
Rebuilding TME may open new doors for improving the prognosis of EGFR mutation patients
2天前
已完结
Integrating Machine Learning-Predicted Circulating Tumor Cells (CTCs) and circulating tumor DNA (ctDNA) in Metastatic Breast Cancer: a proof of principle study on endocrine resistance profiling
2天前
已完结
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
5天前
已完结
New guidelines to evaluate the response to treatment in solid tumors
5天前
已完结
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer
5天前
已完结
Identification of circular RNAs as regulators and noninvasive biomarkers for placenta accreta spectrum
14天前
已完结
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study
18天前
已完结
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
25天前
已完结
CD94 deficiency or blockade unleashes the anti-tumor immunity in mice and humanized murine models
1个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
2个月前
已完结
皖公网安备34019202002308
